The person who runs day-to-day operations for the Biotechnology Innovation Organization and previously did the same for the Department of Health and Human Services is soon to take the reins as CEO of AdvaMed.
Scott Whitaker was approved by AdvaMed's board Feb. 18. He will start in the post April 4, filling an opening left by the October departure of Steve Ubl, who is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?